Exclusive: Efferon raising $20M for pediatric sepsis device

Efferon, a medical device company for pediatric sepsis, is raising a $20 million Series A round, CEO Dima Romashin tells Axios Pro exclusively.

Why it matters: Sepsis is one of the leading causes of childhood morbidity and mortality.